erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Pain D010146 64 associated lipids
Pain, Postoperative D010149 13 associated lipids
Pancreatic Fistula D010185 2 associated lipids
Pancreatitis D010195 10 associated lipids
Papillon-Lefevre Disease D010214 1 associated lipids
Parapsoriasis D010267 1 associated lipids
Paresthesia D010292 7 associated lipids
Parotitis D010309 4 associated lipids
Peliosis Hepatis D010382 1 associated lipids
Pemphigoid, Bullous D010391 8 associated lipids
Peptic Ulcer Hemorrhage D010438 4 associated lipids
Periapical Diseases D010483 4 associated lipids
Pericarditis D010493 6 associated lipids
Pericarditis, Constrictive D010494 1 associated lipids
Pericoronitis D010497 2 associated lipids
Periodontal Abscess D010508 2 associated lipids
Periodontitis D010518 22 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Pharyngeal Diseases D010608 4 associated lipids
Pilonidal Sinus D010864 1 associated lipids
Pityriasis D010915 3 associated lipids
Pleural Diseases D010995 4 associated lipids
Pleural Effusion D010996 3 associated lipids
Pleurisy D010998 20 associated lipids
Pleuropneumonia D011001 3 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Pneumonia D011014 10 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Pneumonia, Mycoplasma D011019 6 associated lipids
Pneumonia, Staphylococcal D011023 2 associated lipids
Porphyrias D011164 2 associated lipids
Postgastrectomy Syndromes D011178 2 associated lipids
Prolapse D011391 1 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Prostatitis D011472 5 associated lipids
Protein-Losing Enteropathies D011504 2 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Psoriasis D011565 47 associated lipids
Psychoses, Substance-Induced D011605 7 associated lipids
Pulmonary Emphysema D011656 3 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pyoderma D011711 5 associated lipids
Quadriplegia D011782 4 associated lipids
Radiodermatitis D011855 3 associated lipids
Rat-Bite Fever D011906 1 associated lipids
Red-Cell Aplasia, Pure D012010 4 associated lipids
Relapsing Fever D012061 3 associated lipids
Respiratory Insufficiency D012131 10 associated lipids
Rhabdomyolysis D012206 9 associated lipids
Rhinitis D012220 10 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Lauenstein TC et al. Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin. 2003 AJR Am J Roentgenol pmid:12704042
Simakova MG et al. [Clinical aspects, diagnosis and treatment of intrauterine infections]. 1995 Akush Ginekol (Mosk) pmid:7485765
Mezinova NN et al. [Effect of anti-chlamydial drugs on the effectiveness of the treatment of habitual abortion]. 1991 Akush Ginekol (Mosk) pmid:1951968
Mezinova NN and Chuchupalov PD [Endometrial Chlamydia infection in women with habitual abortion]. 1992 Akush Ginekol (Mosk) pmid:1476220
Kotua EN and Moroz AF [Erythromycin-ascorbinate therapy of pregnant rats with staphylococcal infections caused by staphylococcal strains both sensitive and resistant to erythromycin]. 1971 Akush Ginekol (Mosk) pmid:5138198
Kotua EN and Moroz AF [Passage of erythromycin and ristomycin into blood, placenta, fetus and amniotic fluid during various stages of pregnancy in generalized staphylococcal infection in albino rats]. 1971 Akush Ginekol (Mosk) pmid:4328638
Thornton JB and Harris JH The prevention of bacterial endocarditis. A new approach to a changing disease. 1986 Ala J Med Sci pmid:3953983
BOURICHON J [Importance of the suppository form in the administration of propionyl-erythromycin to children]. 1962 Alger Medicale pmid:13871918
LEBON J et al. [Staphylococcal diarrhea after terramycin administration; cure by erythromycin]. 1955 Alger Medicale pmid:14398597
Van Herwaarden MA et al. The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients. 2000 Aliment. Pharmacol. Ther. pmid:10759625
Ramirez B and Richter JE Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease. 1993 Aliment. Pharmacol. Ther. pmid:8094981
Catnach SM et al. Dose-dependent stimulation of gallbladder contraction by intravenous erythromycin in man. 1993 Aliment. Pharmacol. Ther. pmid:8439638
Russo A et al. Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis. 2004 Aliment. Pharmacol. Ther. pmid:15274670
Bai Y et al. Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding. 2011 Aliment. Pharmacol. Ther. pmid:21615438
Netzer P et al. Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease. 2002 Aliment. Pharmacol. Ther. pmid:12182748
Chen CL et al. Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease. 2002 Aliment. Pharmacol. Ther. pmid:11929393
Ehrenpreis ED et al. Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis. 1998 Aliment. Pharmacol. Ther. pmid:9690728
Medhus AW et al. Low-dose intravenous erythromycin: effects on postprandial and fasting motility of the small bowel. 2000 Aliment. Pharmacol. Ther. pmid:10651665
Curry JI et al. Review article: erythromycin as a prokinetic agent in infants and children. 2001 Aliment. Pharmacol. Ther. pmid:11328252
Boecxstaens V et al. Modulation of the postprandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility. 2011 Aliment. Pharmacol. Ther. pmid:21517922